CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo

PartnershipTapinarofNeutral
AI Analysis

Summary

CDT partners with QIMA Life Sciences to evaluate novel combinations of Tapinarof for the treatment of psoriasis and vitiligo.

Importance:5/10
Sentiment:
0.00
partnershipdermatologypsoriasisvitiligotapinarof

Read the original article

Published by GlobeNewswire Pharma on September 18, 2026 10:30 AM

Read Original